LOGIN  |  REGISTER
Astria Therapeutics

Life Science Company Leadership Changes

Psychemedics Appoints Shannon Shoemaker as Chief Revenue Officer

September 21
Last Trade: 3.66 -0.07 -1.88

ACTON, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to announce the appointment of Shannon Shoemaker as its new Chief Revenue Officer. In this role, Shoemaker will be responsible for overseeing the company's revenue generation and growth strategies. With an exceptional track record of leadership and a strong background in revenue growth and...Read more


CVS Health appoints Michael F. Mahoney to its Board of Directors

September 21
Last Trade: 71.88 0.47 0.66

WOONSOCKET, R.I., Sept. 21, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, to serve on the Board of Directors (the "Board") of CVS Health, effective November 1. "Mike's focus throughout his career – to drive improvements in health outcomes and increase access to care – align with our mission at CVS...Read more


Royalty Pharma Appoints Eric Schneider as Chief Technology Officer

September 21
Last Trade: 26.26 -1.19 -4.34

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Eric Schneider as Senior Vice President, Chief Technology Officer. Eric will also join Royalty Pharma’s Senior Leadership Committee. Eric joins Royalty Pharma from Verisk, a global leader in data-driven analytic insights and solutions, where he was a Senior Vice President, Chief Data Officer and Chief Technology Officer, and...Read more


Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors

September 21
Last Trade: 1.98 -0.03 -1.49

BRANFORD, Conn. / Sep 21, 2023 / Business Wire / Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Amir Jafri, President and CEO of Immunicom, Inc., to its Board of Directors. “Amir’s leadership track record speaks for itself,” said Jeff Hawkins, CEO of Quantum-Si. “He has successfully managed businesses across multiple industries and has built...Read more


Ocugen Announces Connie Collingsworth Joins Business Advisory Board

September 21
Last Trade: 0.40 0.0044 1.11

MALVERN, Pa., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that Connie Collingsworth, former Chief Operating Officer of the Bill and Melinda Gates Foundation, will join the Company’s Business Advisory Board (BAB). The BAB was established in June...Read more


Aurinia Pharmaceuticals Board of Directors Appoints Dr. Robert T. Foster as New Board Director And Enters Cooperation Agreement with Shareholder MKT Capital

September 21
Last Trade: 8.27 -0.07 -0.84

EDMONTON, Alberta / Sep 21, 2023 / Business Wire / Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that its Board of Directors (“the Board”) has appointed Dr. Robert T. Foster to the Board. MKT Capital Ltd. (together with its affiliates, “MKT Capital”) submitted Dr. Foster as a candidate and worked collaboratively with Aurinia to name him to the Board. In connection with Dr. Foster’s appointment,...Read more


Kiora Pharmaceuticals Appoints Praveen Tyle, PhD, as New Chairman; Succeeds Paul Chaney Who is Retiring After Serving 17 Years

September 21
Last Trade: 0.58 0.03 5.24

Encinitas, California--(Newsfile Corp. - September 21, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced that its board of directors has appointed Praveen Tyle, PhD, who currently serves as a director, as its new Chairman. Dr. Tyle succeeds current Chairman Paul Chaney who is retiring after serving 17 years on the board. "We look forward to Dr. Tyle's leadership as Chairman, where he'll continue to bring valuable industry...Read more


Atrion Announces Election of New Director

September 20
Last Trade: 440.98 -3.05 -0.69

ALLEN, Texas, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced the election today of Jeannette Bankes as a director, effective immediately. Ms. Bankes brings to our Board over 32 years of experience at major medical device and pharmaceutical companies. Since March 2019, Ms. Bankes has served as the President and General Manager of the Global Surgical Franchise at Alcon Inc. From August 2004 to March 2019,...Read more


Stoke Therapeutics Appoints Ian Smith to its Board of Directors

September 20
Last Trade: 4.15 -0.29 -6.53

Mr. Smith brings significant experience in the successful development and commercialization of medicines for rare genetic diseases BEDFORD, Mass. / Sep 20, 2023 / Business Wire / Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced the appointment of Ian Smith to its Board of Directors...Read more


Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors

September 20
Last Trade: 19.30 -1.20 -5.85

PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company’s board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the...Read more


Acadia Pharmaceuticals Appoints Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications

September 19
Last Trade: 23.40 -0.39 -1.64

SAN DIEGO / Sep 19, 2023 / Business Wire / Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications. Mr. Kildani will be responsible for leading investor relations and corporate communications and serve as a member of the company’s Executive Management Committee. He will report to Mark Schneyer, Executive Vice President, Chief...Read more


Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors

September 19
Last Trade: 20.35 -0.20 -0.97

PASADENA, Calif. / Sep 19, 2023 / Business Wire / Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced the appointment of Barbara J. Klencke, M.D., to its board of directors. Dr. Klencke has more than 20 years of biopharmaceutical product development experience, and she most recently served as chief medical...Read more


Praxis Bioresearch Expands its Board of Directors with Appointment of Adam Levy

September 19
Last Trade: 10.72 0.56 5.51

LOS ANGELES, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Praxis Bioresearch (“Praxis”), a biopharmaceutical company focused on the discovery and development of therapeutics for chronic neuropsychiatric and neurodegenerative disorders with an initial focus on apathy in Alzheimer’s Disease, today announced the appointment of Adam Levy to its Board of Directors (the “Board”). Mr. Levy brings executive, financial and operational leadership experience...Read more


Tempest Therapeutics Announces Expanded Role for Sam Whiting, M.D., Ph.D., as Chief Medical Officer and Head of Research and Development

September 19
Last Trade: 0.48 -0.01 -2.15

BRISBANE, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics that combine both targeted and immune-mediated mechanisms, announced today that executive vice president and chief medical officer, Sam Whiting, M.D. Ph.D., has expanded his role to include head of Research and Development. “Sam is an experienced industry drug developer...Read more


Sutro Biopharma Appoints Dr. Hans-Peter Gerber as Chief Scientific Officer

September 19
Last Trade: 3.38 -0.17 -4.79

SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced the appointment of Hans-Peter Gerber, Ph.D., as Chief Scientific Officer, effective September 18, 2023. Dr. Gerber brings over 25 years of drug discovery and development experience to Sutro,...Read more


Replimune Announces Appointment of Emily Hill as Chief Financial Officer

September 19
Last Trade: 16.80 0.18 1.08

WOBURN, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of oncolytic immunotherapies, today announced the appointment of Emily Hill as Chief Financial Officer. Ms. Hill was most recently CFO of the commercial stage biotech company PTC Therapeutics and has more than 15 years of experience in the biotechnology and life...Read more


ImmunoPrecise Antibodies Announces CFO Transition

September 19
Last Trade: 2.07 -0.02 -0.96

Brad McConn to Step Down Later This Month Kristin Taylor, MBA, CPA, Named Interim CFO VICTORIA, British Columbia / Sep 19, 2023 / Business Wire / IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), today announced that it has accepted the resignation of Brad McConn, CFO, effective September 29, 2023. IPA has named Kristin Taylor, MBA, CPA, as interim Chief Financial Officer. “On behalf of IPA, I thank Brad for...Read more


Anixa Biosciences Establishes Cancer Business Advisory Board

September 19
Last Trade: 3.40 0.04 1.19

SAN JOSE, Calif., Sept. 19, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has established a Cancer Business Advisory Board (CBAB), whose purpose is to provide guidance on the Company's clinical and business development initiatives. The CBAB will be co-chaired by Anixa Chairman and CEO, Dr. Amit...Read more


CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer

September 19
Last Trade: 2.02 0.01 0.50

PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly inflammation in critically-ill and cardiac surgery patients around the world, announced the re-appointment of Kathleen P. Bloch as full-time Chief Financial Officer, effective retroactively to September 2, 2023. Ms. Bloch...Read more


Natera Announces Senior Leadership Appointments

September 18
Last Trade: 47.29 -1.87 -3.80

AUSTIN, Texas / Sep 18, 2023 / Business Wire / Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced three appointments within its senior leadership team, effective immediately. Solomon Moshkevich has been promoted to president of clinical diagnostics and will lead Natera’s team of general managers across oncology, women’s health, and organ health. In addition, Moshkevich will have responsibility for...Read more


Catalent Appoints David McErlane as Biologics Segment Leader

September 18
Last Trade: 46.57 -1.68 -3.48

SOMERSET, N.J. / Sep 18, 2023 / Business Wire / Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that David McErlane has been named Group President of Catalent’s Biologics segment, effective September 25, 2023. Mr. McErlane joins Catalent from Lonza, where he served as senior vice president and business unit head for Lonza’s Bioscience business....Read more


AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors

September 18
Last Trade: 17.15 -0.85 -4.72

After more than 15 years serving on AnaptysBio’s Board of Directors, Jamie Topper, M.D., Ph.D., is stepping down and will serve as an advisor to the Board through Q1 2024 SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced it has appointed John Orwin chairman of the AnaptysBio Board of...Read more


COMPASS Pathways appoints Daphne Karydas to its Board of Directors

September 18
Last Trade: 7.96 -0.26 -3.16

LONDON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Daphne Karydas to its Board of Directors, effective September 18, 2023. Ms. Karydas is President and Chief Financial Officer at Flare Therapeutics Inc., a privately held biotechnology company targeting...Read more


Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience

September 18
Last Trade: 10.90 -0.82 -7.00

Welcomes Dr. Connie Hwang as chief medical officer, creates roles of chief health officer and chief nursing officer SEATTLE, Sept. 18, 2023 /PRNewswire/ -- Accolade (Nasdaq: ACCD) announced the expansion of its care delivery team, strengthening the company's ability to streamline healthcare experiences through physician-led advocacy. Connie Hwang, MD, MPH, joins Accolade to lead population health strategies for employers and...Read more


DocGo Appoints Lee Bienstock as Chief Executive Officer

September 18
Last Trade: 5.10 -0.02 -0.39

NEW YORK / Sep 18, 2023 / Business Wire / DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services announced that its Board of Directors has appointed Lee Bienstock, who most recently served as the company’s President and Chief Operating Officer, to the role of Chief Executive Officer, effective September 15, 2023. “Lee has done an exceptional job transforming DocGo through rapid growth since joining us in March 2022,”...Read more


ImmunoGen Appoints Lauren White as Senior Vice President and Chief Financial Officer

September 18
Last Trade: 14.93 0.29 1.98

WALTHAM, Mass. / Sep 18, 2023 / Business Wire / ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Lauren White has been appointed Senior Vice President and Chief Financial Officer. "We are excited to have Lauren join our team and believe that her expertise in financial planning and strategy, operations, and investor relations will be...Read more


Verve Therapeutics Expands Leadership Team with Appointment of Frederick T. Fiedorek, M.D., as Chief Medical Officer

September 18
Last Trade: 12.45 -0.36 -2.81

BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the appointment of Frederick “Fred” T. Fiedorek, M.D., as chief medical officer (CMO). Andrew Bellinger, M.D., Ph.D., the current chief scientific officer (CSO) and CMO, will transition to the role of CSO. “We are...Read more


Black Diamond Therapeutics Announces CEO Transition

September 18
Last Trade: 3.40 -0.05 -1.45

Current Chairman of the Board and industry veteran Mark Velleca appointed CEO CAMBRIDGE, Mass. and NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology company developing therapies that target families of oncogenic mutations in patients with genetically defined cancers, announced that current Chairman of the Board, Mark Velleca, M.D., Ph.D., has been...Read more


Lobe Sciences Announces Appointment of Mathew Lee as CFO

September 18
Last Trade: 0.02 0.005 33.33

VANCOUVER, British Columbia / Sep 18, 2023 / Business Wire / Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical Company committed to discovering and developing patient-focused medicines for Orphan and Rare diseases announced today that Mathew Lee will join the organization as Chief Financial Officer, effective September 18, 2023. “Appointing Mathew is part of our overall long-term...Read more


Pliant Therapeutics Appoints Minnie Kuo as Chief Development Officer

September 15
Last Trade: 15.94 -0.39 -2.39

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced the appointment of Ms. Minnie Kuo as Chief Development Officer. Ms. Kuo will oversee all aspects of the Company’s nonclinical and clinical development activities. “Minnie is an accomplished...Read more


Mineralys Therapeutics Expands its Board of Directors with Appointments of Glenn Sblendorio and Daphne Karydas

September 14
Last Trade: 10.72 0.56 5.51

RADNOR, Pa., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases driven by abnormally elevated aldosterone, today announced the appointments of Daphne Karydas and Glenn Sblendorio to its Board of Directors (the Board). Ms. Karydas and Mr. Sblendorio bring executive,...Read more


Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer

September 14
Last Trade: 1.02 -0.02 -1.92

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 14, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), (Biophytis), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients...Read more


Community Health Systems Announces Appointment of New Independent Director

September 13
Last Trade: 2.89 -0.09 -3.02

FRANKLIN, Tenn. / Sep 13, 2023 / Business Wire / Community Health Systems, Inc. (NYSE: CYH) today announced the appointment of retired U.S. Army Lt. Gen. Ronald L. Burgess Jr. to its Board of Directors for a term expiring at the 2024 Annual Meeting of Stockholders. Cybersecurity, national security and operational leadership have been central to Gen. Burgess’s distinguished career. Gen. Burgess retired from the U.S. Army after 38 years of...Read more


HOOKIPA Pharma Announces Executive Leadership Change

September 13
Last Trade: 0.61 -0.0032 -0.52

NEW YORK and VIENNA, Sept. 13, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that Katia Schlienger, M.D., Ph.D., is stepping down from her position as Chief Medical Officer (CMO) to pursue new opportunities, effective September 30. Malte Peters, M.D., a current member of the Board of Directors of...Read more


Premier Realigns Leadership Team and Promotes Key Executives to Accelerate Innovation and Profitable Growth

September 12
Last Trade: 21.64 -0.15 -0.69

Leigh Anderson is now Chief Operating Officer Andy Brailo is now Chief Commercial Officer Bruce Radcliff is now Senior Vice President of Supply Chain CHARLOTTE, N.C. / Sep 12, 2023 / Business Wire / Premier, Inc. (NASDAQ: PINC) (“Premier” or the “Company”), a leading technology-enabled healthcare improvement company, today announced three executive promotions that strategically position the organization for continued innovation,...Read more


Anavex Life Sciences Announces Appointment of Dr. Marwan N Sabbagh, MD as Chairman of the Scientific Advisory Board

September 12
Last Trade: 6.97 -0.27 -3.73

NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced the appointment of Prof. Dr. Marwan N...Read more


Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board

September 12
Last Trade: 0.68 0.02 3.75

BETHESDA, Md., Sept. 12, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announces that Dr. Linda Liau, MD, PhD, MBA has joined the Company's Scientific Advisory Board (SAB).  Dr. Liau served as the Principal Investigator of the Phase 3 trial of DCVax®-L for treatment of glioblastoma.  She is Chair of the...Read more


Jazz Pharmaceuticals Announces Key Update to Leadership Team

September 12
Last Trade: 132.73 -1.00 -0.75

Renée Galá promoted to President and Chief Operating Officer DUBLIN, Sept. 12, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Renée Galá, Chief Financial Officer, has been promoted to President and Chief Operating Officer effective October 1, 2023. Dan Swisher has notified the company of his intention to retire from his position as President and COO after five and a half years of significant...Read more


DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer

September 12
Last Trade: 3.00 0.02 0.67

Dr. Shah Has Spent Over Two Decades Leading Biological Development Teams at Biotechnology Companies and Has Deep Expertise in Protein Development and Manufacturing MINNEAPOLIS / Sep 12, 2023 / Business Wire / DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, announced today the appointment of Ambarish Shah,...Read more


Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors

September 12
Last Trade: 0.97 -0.01 -1.39

ROSELAND, N.J., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dr. Didier Demesmin, MD, MBA, to the Board of Directors. Dr. Demesmin is an interventional pain medicine physician who is double board-certified in both anesthesiology and pain medicine. He is the founder of...Read more


Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors

September 12
Last Trade: 1.68 -0.04 -2.05

Appointment effective as of September 14, 2023; Zeev Bronfeld to retire from the Board of Directors CARMIEL, Israel, Sept. 12, 2023 /PRNewswire / Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell–based protein expression system, today announced that the...Read more


Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer

September 12
Last Trade: 3.61 -0.19 -5.00

CLEVELAND, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Madhav Vasanthavada, Ph.D., M.B.A. to the role of Chief Commercial Officer (CCO) and Head of Business Development (BD), effective immediately. In this capacity, in addition to his current BD responsibilities, Dr. Vasanthavada will oversee all aspects of commercial strategy, planning and operations as Abeona prepares for...Read more


Repligen Appoints Jason K. Garland as Chief Financial Officer

September 12
Last Trade: 161.72 -6.86 -4.07

WALTHAM, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed Jason K. Garland as Chief Financial Officer (“CFO”), effective September 25, 2023. Mr. Garland is joining Repligen from his most recent role with medical device outsource (MDO) manufacturer Integer Holdings Corporation (“Integer”), where he...Read more


Orthofix Medical Announces Leadership Changes

September 12
Last Trade: 12.70 -0.03 -0.24

Catherine Burzik Appointed Interim Chief Executive Officer Geoffrey Gillespie Appointed Interim Chief Financial Officer Puja Leekha Appointed Interim Chief Legal Officer LEWISVILLE, Texas / Sep 12, 2023 / Business Wire / Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that Catherine Burzik, Chair of the Orthofix Board of Directors, has been appointed Interim Chief Executive...Read more


4D Molecular Therapeutics Appoints Uneek Mehra as Chief Financial and Business Officer

September 12
Last Trade: 14.45 -0.05 -0.34

EMERYVILLE, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines, today announced the appointment of Uneek Mehra as Chief Financial & Business Officer of 4DMT. Mr. Mehra will succeed August J. Moretti, J.D., who is retiring, and has agreed to serve in an advisory...Read more


Shockwave Medical Appoints Nick West as Associate Chief Medical Officer

September 12
Last Trade: 196.88 -7.19 -3.52

SANTA CLARA, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that Nick West, MA, MD, FRCP, FESC, FACC, has joined the company in the role of Associate Chief Medical Officer. Dr. West will report to Keith Dawkins, MD, Chief Medical Officer, and will be based in...Read more


Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors

September 12
Last Trade: 24.82 -0.71 -2.78

BOSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Sensorium Therapeutics (Sensorium), a biotechnology company translating insights from nature and human experience to deliver transformational therapeutics, today announced the appointment of veteran life sciences executive David Southwell to its Board of Directors. “We are excited to welcome David to our Board,” said Dick Simon, Chief Executive Officer of Sensorium. “He is a seasoned life...Read more


Movano Health: Evie Ring Welcomes Cardiologist and Stanford University Associate Professor Dr. Fátima Rodriguez to its Medical Advisory Board

September 12
Last Trade: 1.10 0.00 0.00

Dr. Rodriguez will provide strategic input and medical validation to guide innovation for the Evie Ring  PLEASANTON, Calif., Sept. 12, 2023 /PRNewswire/ -- After recently announcing the establishment of its Medical Advisory Board, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, today shared Dr. Fátima Rodriguez has...Read more


Sight Sciences Appoints Matt Link as Chief Commercial Officer

September 11
Last Trade: 2.96 0.08 2.78

MENLO PARK, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients' lives, today announced the appointment of Matthew Link as its Chief Commercial Officer, effective September 11, 2023. “We are very excited to have Matt join Sight...Read more


Perrigo Announces Leadership Update

September 11
Last Trade: 32.69 -0.68 -2.04

Appoints Experienced Consumer Packaged Goods Executive Catherine "Triona" Schmelter as EVP and President, Consumer Self-Care Americas (CSCA) and Global Portfolio Optimization DUBLIN, Sept. 11, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced the appointment of Catherine "Triona" Schmelter as Executive Vice President and President, Consumer Self-Care Americas...Read more


Geron Announces Appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer and Treasurer, and the Retirement of Olivia Bloom, Geron's Long-Time Chief Financial Officer

September 11
Last Trade: 2.17 0.03 1.40

FOSTER CITY, Calif. / Sep 11, 2023 / Business Wire / Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer (CFO) and Treasurer, effective September 25, 2023. Ms. Robertson's appointment follows the retirement of Olivia Bloom, Geron's incumbent CFO, also effective September 25, 2023. Ms. Bloom's retirement...Read more


Palisade Bio Appoints GI Clinical Expert and Biotech Entrepreneur Mitchell Jones, M.D., Ph.D. as Chief Medical Officer

September 11
Last Trade: 0.58 -0.01 -2.29

Announces Awarding of Inducement Grant to New Chief Medical Officer Carlsbad, CA, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced the appointment of Mitchell Jones, M.D., Ph.D., as Chief Medical Officer. Dr. Jones has a proven track record of...Read more


Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer

September 11
Last Trade: 159.51 -1.91 -1.18

CONSHOHOCKEN, Pa., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today announced that Bill Sibold has succeeded Paul Friedman, M.D., as Chief Executive Officer (CEO) and joined Madrigal’s Board of Directors. Dr. Friedman, who has served as Madrigal’s CEO since 2016, will continue to serve on...Read more


DermTech Appoints Mark Aguillard as Chief Commercial Officer

September 11
Last Trade: 1.70 0.01 0.59

SAN DIEGO / Sep 11, 2023 / Business Wire / DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced the appointment of Mark Aguillard as chief commercial officer effective September 19, 2023. Mr. Aguillard will lead DermTech’s overall commercial strategy and execution. Commenting on Mr. Aguillard’s appointment, Bret Christensen, DermTech’s...Read more


SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer

September 11
Last Trade: 24.14 -0.41 -1.67

STAMFORD, Conn., Sept. 11, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced the appointment of Tai-An Lin, Ph.D., as its Chief Scientific Officer. Dr. Lin brings more than 25 years of biotechnology and global pharmaceutical experience in advancing drug...Read more


Oculis Expands its Executive Leadership Team and Appoints Rebecca Weil, Ph.D. as Chief Commercial Officer as it Enters Pre-Commercial Phase

September 11
Last Trade: 12.22 -0.28 -2.24

Following the achievement of two positive key late-stage clinical milestones on its lead product candidate OCS-01 and recent listing on NASDAQ, Oculis is strengthening its executive leadership team with the appointment of Rebecca Weil, Ph.D., seasoned global ophthalmology commercial executive, as Chief Commercial Officer OCS-01’s recent positive topline results in Phase 3 DIAMOND Stage 1 trial for diabetic macular edema (DME) and in...Read more


GeneDx Announces Evolution of Executive Leadership Team

September 11
Last Trade: 3.65 -0.15 -3.95

STAMFORD, Conn., Sept. 11, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS) a leader in delivering improved health outcomes through genomic and clinical insights, today announced the expansion and evolution of its executive leadership team with the appointment of Melanie Duquette as Chief Growth Officer and Jennifer (Jen) Brendel as Chief of Corporate Affairs. Both executives will report to Katherine Stueland, CEO and President, and will...Read more


Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

September 11
Last Trade: 1.23 0.01 0.82

IRVINE, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced the appointment of James Robinson to its Board of Directors effective October 1, 2023. Mr. Robinson is a seasoned biopharmaceutical executive with over 30 years of experience in the industry, most recently serving as Chief Executive Officer and Director of Urovant Sciences until its merger with Sumitomo Pharma America...Read more


Aspira Women’s Health Announces Dr. Jody Berry as New Chief Scientific Officer

September 11
Last Trade: 4.57 -0.53 -10.39

AUSTIN, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical company focused on the development and commercialization of women’s health diagnostic tools for gynecologic diseases, today announced it has named Jody Berry, Ph.D. as its new Chief Scientific Officer. Dr. Ryan Phan, who stepped down as the Company’s Chief Scientific and...Read more


eFFECTOR Therapeutics Appoints Caroline Loewy to Board of Directors

September 11
Last Trade: 0.51 -0.01 -2.55

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (“STRIs”) for the treatment of cancer, today announced the addition of Caroline Loewy to its Board of Directors and her election as Chair of the Board’s Audit Committee. Concurrent with Ms. Loewy’s appointment, current Board member John...Read more


Dr. Karen Chagin Joins Adaptimmune Therapeutics as Senior Vice President of Early-Stage Development

September 11
Last Trade: 0.77 0.02 3.07

Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - September 11, 2023) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a leader in cell therapy to treat cancer, today announces that Karen Chagin, MD has joined the Company as its Senior Vice President of Early-Stage Development. Dr. Chagin will oversee the Company's early-stage pipeline activities from pre-IND and IND activities through Phase 1 clinical...Read more


Regeneron Pharmaceuticals Announces Updates to Board of Directors

September 8
Last Trade: 823.38 -8.24 -0.99

TARRYTOWN, N.Y., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Kathryn Guarini, Ph.D., and David P. Schenkein, M.D., have joined Regeneron’s Board of Directors effective September 8, 2023. “Today’s announcement demonstrates our strong commitment to strategic refreshment of the Board, a focus on the recruitment of new directors to complement the overall mix of skills, experience and...Read more


Definitive Healthcare Welcomes Scott Stephenson to Board of Directors

September 8
Last Trade: 7.81 0.04 0.51

FRAMINGHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced two changes to its Board of Directors. On September 6, 2023, Scott Stephenson, the former Chief Executive Officer of Verisk Analytics, joined the Board of Directors and the nominating and corporate governance committee of the Board, while Chris Mitchell, managing director...Read more


CVS Health announces additional responsibilities for executive leadership team members

September 7
Last Trade: 71.88 0.47 0.66

WOONSOCKET, R.I., Sept. 7, 2023 /PRNewswire/ -- CVS Health® Corporation (NYSE: CVS) today announced additional responsibilities for several members of the company's executive leadership team, effective immediately: Shawn Guertin will continue as our Chief Financial Officer and is now President of Health Services. Prem Shah will continue as our Chief Pharmacy Officer and is now the sole President of Pharmacy and Consumer...Read more


Celularity Appoints Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors

September 7
Last Trade: 0.24 0.01 5.17

FLORHAM PARK, N.J., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity), a biotechnology company developing placental-derived off-the-shelf allogeneic cell therapies and advanced biomaterial products, today announced the appointment of Geoffrey Shiu Fei Ling, M.D., Ph.D. to its Board of Directors. Dr. Ling, a distinguished academic and military physician-scientist with a strong background in regenerative...Read more


Veracyte Names Marie-Claire Taine, Ph.D., as General Manager of Its IVD Business Unit To Advance Global Expansion of the Company’s Tests

September 7
Last Trade: 22.60 -0.73 -3.13

SOUTH SAN FRANCISCO, Calif. / Sep 07, 2023 / Business Wire / Veracyte, Inc. (Nasdaq: VCYT) announced that Marie-Claire Taine, Ph.D., will join Veracyte as general manager of the company’s in vitro diagnostics (IVD) Business Unit, based in Marseille, France. She will lead the global expansion of Veracyte’s tests and will also serve as site lead for the company’s Marseille operations. Dr. Taine is a highly credentialed commercial operations...Read more


Select Medical Announces Executive Management Appointments

September 7
Last Trade: 25.72 -0.18 -0.69

MECHANICSBURG, Penn., Sept. 7, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced 12 executive management appointments, effective October 1, 2023. John Saich and Thomas Mullin have been promoted to co-presidents of the organization, and Michael Malatesta has been named executive vice president and chief financial officer. A 26-year veteran of Select Medical,...Read more


Inogen Announces CFO Transition Plan

September 7
Last Trade: 5.15 -0.05 -0.96

Names Mike Sergesketter as Interim Chief Financial Officer Reaffirms 2023 Financial Guidance GOLETA, Calif. / Sep 07, 2023 / Business Wire / Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mike Sergesketter as Interim Chief Financial Officer, effective immediately. Mr. Sergesketter last served as Interim Chief...Read more


Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer

September 7
Last Trade: 2.01 -0.08 -3.83

LONDON and SALT LAKE CITY, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), the first company to commercialize an FDA approved artificial intelligence (AI) enabled prognostic blood test for individuals with type 2 diabetes and chronic kidney disease, announces the appointment of Howard Doran as Chief Business Officer, effective September 1, 2023. Mr. Doran’s primary responsibility will be leading the...Read more


CRISPR Therapeutics Announces Leadership Transition

September 7
Last Trade: 46.06 -0.50 -1.07

CRISPR Therapeutics co-founder, Rodger Novak, M.D., to step down as President and Chairman, effective September 15, 2023- Samarth Kulkarni, Ph.D., to succeed Dr. Novak as Chairman and will continue serving as CEO of the Company- ZUG, Switzerland and BOSTON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases,...Read more


Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board

September 7
Last Trade: 0.33 0.007 2.17

SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the establishment of its Prostate Cancer Scientific Advisory Board (SAB). The Prostate Cancer SAB is comprised of distinguished academic and industry leaders in the prostate cancer field, which will advise Oncternal as it develops its...Read more


Elite Pharmaceuticals Appoints Carter Ward as Chief Financial Officer

September 7
Last Trade: 0.09 0.0025 2.89

NORTHVALE, NJ / ACCESSWIRE / September 7, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, today announced the appointment of Carter Ward as its Chief Financial Officer (CFO), effective September 5, 2023. Mr. Ward previously served as the Company's Chief Financial Officer from July 2009 through May 2021, and the Company is...Read more


Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors

September 6
Last Trade: 0.48 0.02 3.94

FORT LAUDERDALE, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced the appointment of Scott Durbin to the Company’s Board of Directors (the “Board”). Mr. Durbin has more than 25 years of executive leadership, finance and clinical development experience, including the execution of...Read more


SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer

September 6
Last Trade: 4.68 0.09 1.96

NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Jay K. Varma has joined SIGA as Executive Vice President and Chief Medical Officer (CMO). He will also continue to serve as a director of the SIGA Board of Directors. “As SIGA has worked to support the global response to the MPOX outbreak and...Read more


Oscar Health Welcomes Two Healthcare Veterans to its Executive Leadership Team

September 6
Last Trade: 5.75 -0.17 -2.87

NEW YORK / Sep 06, 2023 / Business Wire / Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built around a full stack technology platform, today announced the appointment of two seasoned healthcare executives to round out its leadership bench and further propel its vision to refactor healthcare. Kerry Sain has joined the company as the Executive Vice President of +Oscar, effective August 14, 2023, and Steven...Read more


Capricor Therapeutics Appoints Michael Kelliher to Board of Directors

September 6
Last Trade: 5.45 -0.35 -6.03

SAN DIEGO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, today announced that the Company has appointed Michael Kelliher to its Board of Directors, effective immediately. Mr. Kelliher, Group Vice President of M&A and Business...Read more


Hepion Pharmaceuticals Announces Management Changes

September 6
Last Trade: 5.57 0.05 0.91

EDISON, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-assisted therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”), and other chronic diseases, announced that Stephen Harrison, M.D., has been appointed as Consultant Medical...Read more


Biogen Appoints Jane Grogan as Head of Research

September 6
Last Trade: 258.93 -1.60 -0.61

CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the appointment of Jane Grogan, Ph.D., as Executive Vice President, Head of Research effective 2 October 2023. Dr. Grogan will be a member of Biogen’s Executive Committee reporting to Christopher A. Viehbacher, President and Chief Executive Officer. “Dr. Grogan is a pioneering scientist whose groundbreaking discoveries at Genentech helped pave the...Read more


Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO

September 6
Last Trade: 1.36 -0.03 -2.16

FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) --  Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors and departing the Company effective September 5, 2023, with Enzo’s Chief Operating Officer, Kara Cannon, assuming the role of interim CEO. “We thank Hamid for the commitment he has brought to Enzo Biochem, Inc.” ...Read more


Mersana Therapeutics Announces Changes in Leadership

September 6
Last Trade: 1.26 -0.01 -0.79

Anna Protopapas to retire as President and Chief Executive Officer (CEO); will remain a member of the Board of Directors Martin Huber, M.D., current member of the Board of Directors, to be named President and CEO Brian DeSchuytner named Chief Operating Officer; Mohan Bala, Ph.D., named Chief Development Officer CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage...Read more


Cell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard Bauer, Joins Orgenesis Business, Octomera, to Drive Continued Expansion of POCare Facilities and Service Support

September 6
Last Trade: 0.59 0.0022 0.37

GERMANTOWN, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Orgenesis, a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), continues to grow the infrastructure of the advanced therapeutic POCare services and facilities supply business, Octomera. The appointment of Gerhard Bauer as the Vice President of Global Product Implementation at Octomera has been made to enhance the existing process development,...Read more


Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD

September 6
Last Trade: 0.67 -0.02 -3.16

LOS ALTOS, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced the appointment of Sara Kenkare-Mitra, PhD to the Company’s Board of Directors, effective September 6, 2023. As a veteran of the biotech and pharmaceutical industry, we believe Sara’s leadership...Read more


ALX Oncology Realigns Executive Leadership Team

September 6
Last Trade: 5.02 0.20 4.15

Jason Lettmann appointed as Chief Executive Officer Dr. Jaume Pons transitions to Chief Scientific Officer SOUTH SAN FRANCISCO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced that Jason Lettmann, a member of the Board of Directors, will succeed Jaume...Read more


Alignment Healthcare Welcomes New Chief Medical Officer

September 6
Last Trade: 6.61 0.21 3.28

ORANGE, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced the return of Dr. Hyong (Ken) Kim, as its chief medical officer (CMO) effective Sept. 25. Dr. Kim will report to company Founder and CEO John Kao. Dr. Kim played an integral role in Alignment’s founding and, from 2013 to 2018, served as CMO of Alignment Healthcare, where he co-developed, built and managed Alignment’s clinical...Read more


TriSalus Life Sciences Appoints Jodi Devlin as President of TriSalus Therapeutics

September 6
Last Trade: 5.59 0.09 1.64

Devlin Brings Significant Expertise in Commercialization, Sales and Marketing DENVER / Sep 06, 2023 / Business Wire / TriSalus Life Sciences® Inc., (TriSalus or the Company), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today announced that Jodi Devlin has joined the Company as President of TriSalus Therapeutics. In this newly...Read more


Quince Therapeutics Appoints Dr. Charles S. Ryan as President

September 6
Last Trade: 1.17 -0.04 -3.31

SOUTH SAN FRANCISCO, Calif. / Sep 06, 2023 / Business Wire / Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today announced the appointment of Charles S. Ryan, J.D., Ph.D. as President. In this new position, Dr. Ryan will be responsible for the company’s corporate legal activities and intellectual property...Read more


MaxCyte Appoints Ali Soleymannezhad as Executive Vice President of Bioprocessing

September 6
Last Trade: 3.20 0.03 0.95

ROCKVILLE, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced the appointment of Ali Soleymannezhad as Executive Vice President of Bioprocessing, effective...Read more


C4 Therapeutics Announces Chief Financial Officer Succession

September 5
Last Trade: 2.19 -0.02 -0.90

WATERTOWN, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced the appointment of Kendra Adams as chief financial officer (CFO), effective September 18, 2023. She will succeed Lauren White, who...Read more


Organon Bolsters Research & Development Expertise with Two Leadership Appointments

September 5
Last Trade: 18.58 -0.35 -1.85

JERSEY CITY, N.J. / Sep 05, 2023 / Business Wire / Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced the appointment of Juan Camilo Arjona Ferreira, M.D., as Chief Medical Officer (CMO) and Charlotte Owens, M.D., as Head of Medical Affairs and Outcomes Research, strengthening the company’s global clinical and medical capabilities, advancing external relationships and fueling efforts to bring...Read more


MultiPlan Announces New Additions to Senior Leadership Team

September 5
Last Trade: 1.78 0.00 0.00

Appointment of new SVP of Marketing and Communications and SVP of Products support the next phase of the Company’s Growth Plan NEW YORK / Sep 05, 2023 / Business Wire / MultiPlan Corporation (NYSE: MPLN) (“MultiPlan” or the “Company”), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced the...Read more


Sign Up To Get Daily Health Stock News

Please review our Disclaimer and Privacy Policy before subscribing.

Featured Stock

Surmodics

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...

CLICK TO LEARN MORE

COPYRIGHT ©2023 HEALTH STOCKS HUB